The latest news about Lumendi
July 1, 2023
| News | Press Release | Products
A Randomized Prospective Study Evaluating Effectiveness Of A Double Balloon Endolumenal Platform For Colorectal EndoscopicSubmucosal Dissection
Endoscopic removal of colonic polyps and early cancers eliminates the need for surgical resection and possible temporary or permanent colostomy.
February 16, 2023
| DiLumen C¹ | Grasper | News | Press Release | Products
Lumendi Receives 510(k) Clearance for Two New Devices
Company Achieves New Milestone with Over 4,000 Therapeutic Procedures Completed Across the U.S., Europe and Asia, Using DiLumen™ Endoluminal Interventional Platform February 16, 2023 08:00 AM Eastern Standard Time WESTPORT,… Continue reading Lumendi Receives 510(k) Clearance for Two New Devices
February 16, 2022
| DiLumen C¹ | DiLumen EZ¹ | News | Products
Lumendi receives 510k clearance for two new devices
Company Achieves New Milestone with Over 4,000 Therapeutic Procedures Completed Across the U.S., Europe and Asia, Using DiLumen™ Endoluminal Interventional Platform February 16, 2023 08:00 AM Eastern Standard Time WESTPORT,… Continue reading Lumendi receives 510k clearance for two new devices
December 9, 2021
| Homepage | Products
30% of surgical interventions are unnesessary
Dr. Peter Johann, CEO & Founder of Lumendi and Prof. Bauerfeind discussed how treatment methods such as EMR and ESD can be made more accessible to patients. Prof. Bauerfeind: "Sometimes these treatments… Continue reading 30% of surgical interventions are unnesessary
May 6, 2021
| Homepage | News | Products
Introducing EZ Glide in Europe
Many studies have documented that an endoscopic approach for ESD is a safer and less expensive alternative to removing these polyps, leading to fewer postoperative complications and shorter hospital stays.